Literature DB >> 9928074

The effect of vasoactive intestinal peptide (VIP) and inhibition of nitric oxide synthase on survival rate in rats exposed to endotoxin shock.

N Tunçel1, F C Töre.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9928074     DOI: 10.1111/j.1749-6632.1998.tb11241.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  6 in total

1.  Effects of sepsis on mast cells in rat dura mater: influence of L-NAME and VIP.

Authors:  F Tore; A M Reynier-Rebuffel; N Tuncel; J Callebert; P Aubineau
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

2.  Vasoactive intestinal peptide enhances striatal plasticity and prevents dopaminergic cell loss in Parkinsonian rats.

Authors:  OrhanTansel Korkmaz; Hakan Ay; Emel Ulupinar; Neşe Tunçel
Journal:  J Mol Neurosci       Date:  2012-04-29       Impact factor: 3.444

3.  The effects of vasoactive intestinal peptide on dura mater nitric oxide levels and vessel-contraction responses in sympathectomized rats.

Authors:  Fatma Tore; Orhan Tansel Korkmaz; Dilek Dogrukol-Ak; Nese Tunçel
Journal:  J Mol Neurosci       Date:  2009-11-20       Impact factor: 3.444

4.  Effect of fluoxetine on depression-induced changes in the expression of vasoactive intestinal polypeptide and corticotrophin releasing factor in rat duodenum.

Authors:  Yong-Lan Huang; Jie-Ping Yu; Gao-Hua Wang; Zhen-Hua Chen; Qing Wang; Ling Xiao
Journal:  World J Gastroenterol       Date:  2007-12-07       Impact factor: 5.742

5.  VIP inhibits human HepG2 cell proliferation in vitro.

Authors:  Afaf Absood; Bin Hu; Nermine Bassily; Lisa Colletti
Journal:  Regul Pept       Date:  2007-11-21

6.  VPAC1 receptor expression in peripheral blood mononuclear cells in a human endotoxemia model.

Authors:  Angela Storka; Bernhard Burian; Gerhard Führlinger; Breanna Clive; Terri Sun; Richard Crevenna; Andrea Gsur; Wilhelm Mosgöller; Michael Wolzt
Journal:  J Transl Med       Date:  2013-05-07       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.